EpitogenX Ltd is a forward-thinking biotechnology company delivering high-quality products and services for research, diagnostics, and vaccine studies across both human and veterinary healthcare.

We specialize in the development and supply of recombinant antigens, antibodies, and advanced immunoassay solutions, supporting biomarker discovery, translational research, in vitro diagnostic (IVD) development, and immunogenicity assessment. Our proprietary Epitogen® Scaffold Technology enables the efficient expression and presentation of complex linear and conformational epitopes, improving assay performance, consistency, and scalability.

By integrating our AI epitope application into protein engineering, we help partners overcome long-standing challenges in antigen production for autoimmune, infectious, and chronic diseases, as well as in vaccine design and evaluation.

Our antibodies and recombinant products are referenced in 100+ peer-reviewed publications, reflecting strong independent validation across academic and industrial research.

Our platform supports:

✔ Academic and clinical research
✔ Diagnostic and vaccine developers
✔ OEM and CRO partners
✔ Biotech and pharmaceutical companies
✔ Veterinary and zoonotic disease programs

📍 Based in the UK | Serving global partners

EpitogenX

Org chart

Teams

Offices